TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Gallo, Montagnier, Four Others Share Japan Prize; RPMI, First Cancer Center, 90 Years Old May 20, 1988